Conserv Bioscience
Conserv Bioscience is a startup headquartered in London, United Kingdom, founded in 2020. It has won about £1.66m in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Conserv Bioscience has won about £1.66m in competitive Innovate UK grants since 2023.
- UNICOR-v, a pancoronavirus vaccine (£976k, 2023)
- A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections. (£680k, 2023)
R&D ecosystem
Conserv Bioscience sits inside the London and the Golden Triangle R&D ecosystem in the Global R&D Labs Directory.
Other startups in London
- Abtrace
- Adjsoft
- Aeon Energy
- Amphibio
- Anserine Labs
- APIContext
- Apoha
- AppyParking
- Archangel Lightworks
- Arda Biomaterials
- Bark
Related
- Innovation profile of London
- United Kingdom: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Conserv Bioscience do?
Conserv Bioscience works in pharmaceuticals. Its Innovate UK projects include: UNICOR-v, a pancoronavirus vaccine.
Where is Conserv Bioscience based?
Conserv Bioscience is headquartered in London, United Kingdom.
When was Conserv Bioscience founded?
Conserv Bioscience was founded in 2020.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.